ICOSLG Antikörper (C-Term)
Kurzübersicht für ICOSLG Antikörper (C-Term) (ABIN2287336)
Target
Alle ICOSLG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 216-246, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- ICOSLG, CT (ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653, ICOS ligand, B7 homolog 2, B7-like protein Gl50, B7-related protein 1, CD275)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- ICOSLG antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 216-246 amino acids from the C-terminal region of human ICOSLG.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Andere Bezeichnung
- ICOSLG
-
NCBI Accession
- NP_056074
-
UniProt
- O75144
-
Pathways
- Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Target
-